Xenetic Biosciences (XBIO) Depreciation & Amortization - Total (2011 - 2013)

Xenetic Biosciences (XBIO) has reported Depreciation & Amortization - Total for 3 consecutive years, with $18283.0 the latest figure, recorded in Q4 2013.

• For the quarter ending Q4 2013, Depreciation & Amortization - Total rose 244.12% year-over-year to $18283.0; the trailing twelve-month figure through Nov 2013 stood at $38545.0 (up 97.86% YoY), and the FY2013 full-year result was $38545.0, up 97.86% from the prior year.
• Depreciation & Amortization - Total slipped to $18283.0 in Q4 2013 per XBIO's latest filing, from $22606.0 in the prior quarter.
• Across five years, Depreciation & Amortization - Total topped out at $22606.0 in Q3 2013 and bottomed at -$7657.0 in Q1 2013.
• Historically, Depreciation & Amortization - Total has averaged $6840.9 across 3 years, with a median of $5313.0 in 2012.
• The widest YoY moves for Depreciation & Amortization - Total: up 325.48% in 2013, down 316.18% in 2013.
• Over 3 years, Depreciation & Amortization - Total stood at $3542.0 in 2011, then soared by 50.0% to $5313.0 in 2012, then surged by 244.12% to $18283.0 in 2013.
• According to Business Quant data, Depreciation & Amortization - Total over the past three periods registered $18283.0, $22606.0, and $5313.0 for Q4 2013, Q3 2013, and Q2 2013 respectively.